Matches in SemOpenAlex for { <https://semopenalex.org/work/W2181010303> ?p ?o ?g. }
- W2181010303 endingPage "480" @default.
- W2181010303 startingPage "473" @default.
- W2181010303 abstract "To compare the efficacy and safety of certolizumab pegol (CZP) with and without loading dose (LD) in a post-hoc analysis of two Japanese clinical studies.Data from the double-blind trials (DBT) J-RAPID and HIKARI, and their open-label extension (OLE) studies, were used. Patients randomized to CZP 200 mg every 2 weeks (Q2W) groups starting with LD (400 mg Weeks 0/2/4; LD group; J-RAPID: n = 82, HIKARI: n = 116) and patients randomized to placebo groups who subsequently started CZP Q2W without LD in the OLEs (No-LD group; J-RAPID: n = 61, HIKARI: n = 99) were analyzed. Efficacy and pharmacokinetics were assessed during 24 weeks. Adverse events were reported from all studies.In both trials, the LD groups showed more rapid initial ACR20/50/70 kinetics, and maintained higher ACR50/70 responses until 24 weeks, compared with the No-LD groups. Anti-CZP antibody development was less frequent in the LD groups (J-RAPID: 1.2% versus 4.9%; HIKARI: 17.2% versus 27.3%). Similar safety profiles were reported between LD and No-LD groups (any AEs: 281.8 versus 315.7 [J-RAPID], 282.6 versus 321.3 [HIKARI] [incidence rate/100 patient-years]).Despite limitations, including comparing DBT and OLE studies, these results suggest that a CZP LD improves clinical response in active rheumatoid arthritis without altering the safety profile." @default.
- W2181010303 created "2016-06-24" @default.
- W2181010303 creator A5009147715 @default.
- W2181010303 creator A5010733704 @default.
- W2181010303 creator A5015953107 @default.
- W2181010303 creator A5031710130 @default.
- W2181010303 creator A5044442302 @default.
- W2181010303 creator A5053803963 @default.
- W2181010303 creator A5063192431 @default.
- W2181010303 creator A5069911688 @default.
- W2181010303 creator A5075284186 @default.
- W2181010303 creator A5082654587 @default.
- W2181010303 creator A5083044716 @default.
- W2181010303 creator A5083314956 @default.
- W2181010303 creator A5089659933 @default.
- W2181010303 date "2015-12-14" @default.
- W2181010303 modified "2023-10-13" @default.
- W2181010303 title "<i><b>Post-hoc</b></i> analysis showing better clinical response with the loading dose of certolizumab pegol in Japanese patients with active rheumatoid arthritis" @default.
- W2181010303 cites W1974402687 @default.
- W2181010303 cites W2006566716 @default.
- W2181010303 cites W2031494385 @default.
- W2181010303 cites W2065288134 @default.
- W2181010303 cites W2092241752 @default.
- W2181010303 cites W2094872232 @default.
- W2181010303 cites W2106814980 @default.
- W2181010303 cites W2133832905 @default.
- W2181010303 cites W2152348310 @default.
- W2181010303 cites W2163817180 @default.
- W2181010303 cites W2168841149 @default.
- W2181010303 cites W4252809665 @default.
- W2181010303 doi "https://doi.org/10.3109/14397595.2015.1109182" @default.
- W2181010303 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4898155" @default.
- W2181010303 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26472043" @default.
- W2181010303 hasPublicationYear "2015" @default.
- W2181010303 type Work @default.
- W2181010303 sameAs 2181010303 @default.
- W2181010303 citedByCount "8" @default.
- W2181010303 countsByYear W21810103032015 @default.
- W2181010303 countsByYear W21810103032016 @default.
- W2181010303 countsByYear W21810103032017 @default.
- W2181010303 countsByYear W21810103032018 @default.
- W2181010303 countsByYear W21810103032020 @default.
- W2181010303 countsByYear W21810103032022 @default.
- W2181010303 crossrefType "journal-article" @default.
- W2181010303 hasAuthorship W2181010303A5009147715 @default.
- W2181010303 hasAuthorship W2181010303A5010733704 @default.
- W2181010303 hasAuthorship W2181010303A5015953107 @default.
- W2181010303 hasAuthorship W2181010303A5031710130 @default.
- W2181010303 hasAuthorship W2181010303A5044442302 @default.
- W2181010303 hasAuthorship W2181010303A5053803963 @default.
- W2181010303 hasAuthorship W2181010303A5063192431 @default.
- W2181010303 hasAuthorship W2181010303A5069911688 @default.
- W2181010303 hasAuthorship W2181010303A5075284186 @default.
- W2181010303 hasAuthorship W2181010303A5082654587 @default.
- W2181010303 hasAuthorship W2181010303A5083044716 @default.
- W2181010303 hasAuthorship W2181010303A5083314956 @default.
- W2181010303 hasAuthorship W2181010303A5089659933 @default.
- W2181010303 hasBestOaLocation W21810103031 @default.
- W2181010303 hasConcept C112705442 @default.
- W2181010303 hasConcept C120665830 @default.
- W2181010303 hasConcept C121332964 @default.
- W2181010303 hasConcept C126322002 @default.
- W2181010303 hasConcept C142724271 @default.
- W2181010303 hasConcept C168563851 @default.
- W2181010303 hasConcept C197934379 @default.
- W2181010303 hasConcept C198451711 @default.
- W2181010303 hasConcept C204787440 @default.
- W2181010303 hasConcept C27081682 @default.
- W2181010303 hasConcept C2776215756 @default.
- W2181010303 hasConcept C2777575956 @default.
- W2181010303 hasConcept C2780132546 @default.
- W2181010303 hasConcept C2992886853 @default.
- W2181010303 hasConcept C535046627 @default.
- W2181010303 hasConcept C61511704 @default.
- W2181010303 hasConcept C67761136 @default.
- W2181010303 hasConcept C71924100 @default.
- W2181010303 hasConcept C90924648 @default.
- W2181010303 hasConceptScore W2181010303C112705442 @default.
- W2181010303 hasConceptScore W2181010303C120665830 @default.
- W2181010303 hasConceptScore W2181010303C121332964 @default.
- W2181010303 hasConceptScore W2181010303C126322002 @default.
- W2181010303 hasConceptScore W2181010303C142724271 @default.
- W2181010303 hasConceptScore W2181010303C168563851 @default.
- W2181010303 hasConceptScore W2181010303C197934379 @default.
- W2181010303 hasConceptScore W2181010303C198451711 @default.
- W2181010303 hasConceptScore W2181010303C204787440 @default.
- W2181010303 hasConceptScore W2181010303C27081682 @default.
- W2181010303 hasConceptScore W2181010303C2776215756 @default.
- W2181010303 hasConceptScore W2181010303C2777575956 @default.
- W2181010303 hasConceptScore W2181010303C2780132546 @default.
- W2181010303 hasConceptScore W2181010303C2992886853 @default.
- W2181010303 hasConceptScore W2181010303C535046627 @default.
- W2181010303 hasConceptScore W2181010303C61511704 @default.
- W2181010303 hasConceptScore W2181010303C67761136 @default.
- W2181010303 hasConceptScore W2181010303C71924100 @default.
- W2181010303 hasConceptScore W2181010303C90924648 @default.
- W2181010303 hasIssue "4" @default.
- W2181010303 hasLocation W21810103031 @default.